Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
Neural Stem Cell-Derived Neurons (1 trial)
Parkinson Disease (Phase 2)
Trials (1 total)
Trial APIs (1 total)